6ge4 Citations

Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface.

Protein Sci 27 1810-1820 (2018)
Related entries: 6ge3, 6ge5, 6ge6, 6gec, 6gee, 6geg, 6gei, 6gek

Cited: 16 times
EuropePMC logo PMID: 30058229

Abstract

Many interactions between proteins are mediated by intrinsically disordered regions (IDRs). Intrinsically disordered proteins (IDPs) do not adopt a stable three-dimensional structure in their unbound form, but they become more structured upon binding to their partners. In this communication, we study how a bound IDR adapts to mutations, preventing the formation of hydrogen bonds at the binding interface that needs a precise positioning of the interacting residues to be formed. We use as a model the YAP:TEAD interface, where one YAP (IDP) and two TEAD residues form hydrogen bonds via their side chain. Our study shows that the conformational flexibility of bound YAP and the reorganization of water molecules at the interface help to reduce the energetic constraints created by the loss of H-bonds at the interface. The residual flexibility/dynamic of bound IDRs and water might, therefore, be a key for the adaptation of IDPs to different interface landscapes and to mutations occurring at binding interfaces.

Articles - 6ge4 mentioned but not cited (1)

  1. Adaptation of the bound intrinsically disordered protein YAP to mutations at the YAP:TEAD interface. Mesrouze Y, Bokhovchuk F, Izaac A, Meyerhofer M, Zimmermann C, Fontana P, Schmelzle T, Erdmann D, Furet P, Kallen J, Chène P. Protein Sci 27 1810-1820 (2018)


Reviews citing this publication (5)

  1. Templated folding of intrinsically disordered proteins. Toto A, Malagrinò F, Visconti L, Troilo F, Pagano L, Brunori M, Jemth P, Gianni S. J Biol Chem 295 6586-6593 (2020)
  2. Matrin3: Disorder and ALS Pathogenesis. Salem A, Wilson CJ, Rutledge BS, Dilliott A, Farhan S, Choy WY, Duennwald ML. Front Mol Biosci 8 794646 (2021)
  3. Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers. Howard A, Bojko J, Flynn B, Bowen S, Jungwirth U, Walko G. Exp Dermatol 31 1477-1499 (2022)
  4. Leveraging Hot Spots of TEAD-Coregulator Interactions in the Design of Direct Small Molecule Protein-Protein Interaction Disruptors Targeting Hippo Pathway Signaling. Zhao B, Pobbati AV, Rubin BP, Stauffer S. Pharmaceuticals (Basel) 16 583 (2023)
  5. Assays Used for Discovering Small Molecule Inhibitors of YAP Activity in Cancers. Maity S, Gridnev A, Misra JR. Cancers (Basel) 14 1029 (2022)

Articles citing this publication (10)